NRX Pharmaceuticals, Inc. - Common Stock — 貸借対照表 (NASDAQ:NRXP) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

総資産 6.05 M32.73 M25.82 M7.32 M3.65 M12.96 M 負債合計 3.28 M11.92 M18.41 M19.05 M26.87 M28.89 M 純資産合計 2.77 M20.81 M7.41 M-11.73 M-23.22 M-15.94 M 負債および純資産合計 6.05 M32.73 M25.82 M7.32 M3.65 M12.96 M 有利子負債合計 ———2.82 M6.58 M0 純負債 ———2.82 M5.13 M-7.8 M

ニュース

NRx Pharmaceuticals: 'Sell' On ZYESAMI/NRX-101 Failures & Depression Market Uncertainty (NASDAQ:NRXP)

NRx Pharmaceuticals, Inc. (NRXP) Q1 2026 Earnings Call Transcript

NRx Pharmaceuticals, Inc. (NRXP) Reports Q1 Loss, Lags Revenue Estimates

NRx Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earning

NRx Pharmaceuticals, Inc. (NRXP) Surpasses Q4 Earnings Estimates

NRx Pharmaceuticals, Inc. (NRXP) Shareholder/Analyst Call Prepared Remarks Transcript

NRx Pharmaceuticalsが生物学的同等性でFDAから承認通知を受領

NRx Pharmaceuticals receives FDA bioequivalence approval notice

NRx Pharmaceuticals、NRX-100の医薬品申請でFDAの指針を受領

NRx Pharmaceuticals receives FDA guidance on NRX-100 drug application

VTSAX vs. VTI: Which Vanguard Fund Should You Buy in 2026? - TipRanks.com

H.C. Wainwrightが NRx Pharmaceuticals の目標株価を45ドルに引き上げ